Canadian developers of an autonomous ultrasound device this week unveiled a collaboration to evaluate the clinical application of a wearable patch that could be “a transformative advancement in medical diagnostic technology.”
Vancouver-based Sonus Microsystems is partnering with local clinic Kinetix Medicine to battle-test the Sonus Patch via a trial slated to begin in 2026 and end in 2027.
The clinical trial, designed and executed by Kinetix in collaboration with Sonus, “represents a key milestone for Sonus as we move from technology development toward clinical validation,” says Hani Eskandari, chief executive officer of Sonus.
Sonus is on a “journey to improve patient monitoring by providing real-time AI-powered insights to enable healthcare providers to receive continuous, high-resolution imaging, even outside the medical setting,” according to the CEO.
“We believe this trial will generate critical data to support the use of the Sonus Patch as a new wearable device that allows patients to access continuous ultrasound monitoring,” Eskandari stated.
Dr. Sanjiv Bhalla, a Diagnostic and Interventional Radiologist and Emergency Physician who cofounded Kinetix, affirms the study will be “an important step in validating a technology with the potential to transform patient monitoring.”
At the heart of Sonus’ innovation is its proprietary Array Technology, a polymer-based MEMS transducer system designed to deliver intelligent imaging that brings hospital-grade echocardiography to the home, empowering clinicians with real-time data to better manage chronic conditions remotely.
According to Bhalla, “The real power of the Sonus technology is continuous physiologic insights enabling continuous monitoring in real time, which provides crucial information for early intervention,” adding that there is “exciting potential for its use in adjacent areas.”
“The ability to obtain continuous imaging data directly from a wearable ultrasound patch could allow earlier detection of cardiac dysfunction, blood clots, or other life-threatening conditions, with broad implications for both acute and chronic care,” the physician posits.
Earlier this year, Sonus joined Providence Health Care Ventures’ Innovation Program.
Sonus Microsystems was founded in 2019. Kinetix Medicine was established in 2007.
Leave a Reply